Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc PMEDF


Primary Symbol: C.PMED

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Post by chrispion Jan 25, 2021 11:08pm
192 Views
Post# 32383832

great news in today's PR

great news in today's PRPredictMedix Corporate Update (Jan 25/2021)


I think today's update gives even more clarity on what was spoken about in previous interviews and PRs and gives new insight into what they are working on.
 
Did you ever hear/read these nuggets before? I can guarantee you did not.
 
  • Predictmedix and Juiceworks’ Safe Entry Station will be showcased in a Live event on Jan 26, 2021 in New York City by Wellness4Humanity.
  • Predictmedix and Juiceworks is currently working with one of the largest metal detector manufacturers in North America to design a solution which integrates our infectious disease symptom screening solution with metal detectors. This will allow Predictmedix to launch a competitive product in the full body scanner market as well.
  • Predictmedix has engaged with Norlan Consulting Group Ltd to target the public sector in Canada.
  • Predictmedix has executed a LOI (“Letter of Intent”) with one of the largest and most prestigious North American business consulting firms with global operations and is currently working on business development initiatives along with a definitive sales agreement.
  • Our resellers have ramped up (which means increased their sales person headcount) their sales team to target strategic sectors for our technologies.
  • Currently under discussions with major corporations to start Cannabis & Alcohol impairment testing pilots in North America.
  • Marketing and sales efforts have been ramped up to identify beta partners targeting strategic sectors in North America.

I think today's update gives even more clarity on what was spoken about in previous interviews and PRs and gives new insight into what they are working on such as:
 
  • Predictmedix and Juiceworks’ Safe Entry Station will be showcased in a Live event on Jan 26, 2021 in New York City by Wellness4Humanity.
  • Predictmedix and Juiceworks is currently working with one of the largest metal detector manufacturers in North America to design a solution which integrates our infectious disease symptom screening solution with metal detectors. This will allow Predictmedix to launch a competitive product in the full body scanner market as well.
  • Predictmedix has engaged with Norlan Consulting Group Ltd to target the public sector in Canada.
  • Predictmedix has executed a LOI (“Letter of Intent”) with one of the largest and most prestigious North American business consulting firms with global operations and is currently working on business development initiatives along with a definitive sales agreement.
  • Our resellers have ramped up (which means increased their sales person headcount) their sales team to target strategic sectors for our technologies.
  • Currently under discussions with major corporations to start Cannabis & Alcohol impairment testing pilots in North America.
  • Marketing and sales efforts have been ramped up to identify beta partners targeting strategic sectors in North America.

<< Previous
Bullboard Posts
Next >>